Eagle Bay Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Eagle Bay Advisors's AMGN Position: Q2 2026 in Review
Eagle Bay Advisors increased its Amgen (AMGN) stake by 5.1% in Q2 2026, buying an estimated $20.5K and bringing the position to 1,233 shares worth $447K. The position accounts for 0.33% of the portfolio, ranked #67.
Eagle Bay Advisors first reported a position in AMGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $590K in Q2 2022. 3,157 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Eagle Bay Advisors held 1,233 shares of Amgen worth $447K as of Q2 2026.
- Eagle Bay Advisors bought 60 Amgen shares in Q2 2026, an estimated $20.5K.
- Amgen made up 0.33% of Eagle Bay Advisors's portfolio in Q2 2026, its #67 holding.
- Eagle Bay Advisors first reported a position in Amgen in Q2 2021 and has held it in 21 quarters since.
- Eagle Bay Advisors's Amgen position peaked at $590K in Q2 2022.
- 3,157 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Eagle Bay Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.